Company profile
Panamera Holdings Corporation
OTC: PHCI · Healthcare · Medical - Care Facilities
#1027 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
31DFH 32DQ 14GM 63SS 33
v0.1 · 65/100 weight · provisional
↑ revenue growth (YoY), balance-sheet leverage · ↓ Altman-Z, Piotroski F
Methodology →Revenue TTM
$188.5k
Rev growth YoY (TTM)
-11.1%
Net income (FY)
-$536.4k
Employees
3
as of 2026-08-14
Market cap
$184.7M
as of 2026-08-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$126.3k$126.3k2025
Net income-$536.4k-$536.4k2025
Operating income-$545.7k-$545.7k2025
Total assets$803.5k$803.5k2025
Liabilities$179.1k$179.1k2025
Equity$624.5k$624.5k2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY23
FY25
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Panamera Holdings Corporation’s revenue?
Panamera Holdings Corporation booked $126.3k in FY2025 revenue, growing 1015% year over year — faster than 96% of Healthcare companies we track, at a -424.8% net margin.
Peers · Healthcare
Endonovo Therapeutics, Inc.——Serina Therapeutics, Inc.41DVentriPoint Diagnostics Ltd.31DCandel Therapeutics, Inc.33DAinos, Inc.41DAdvanced BioMedical Technologies Inc.——Neighbors
Oklahoma →Key facts
CEOBlair Aiken
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersEdmond, OK
ExchangeOTC: PHCI
Employees3
IPO date2021-04-21
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.